Matthew Kucmanic, MA, MPH and Amy R. Sheon, PhD, MPH
Using focus groups to obtain stakeholder feedback can lead to epistemic injustices if the decision-making process is not perceived as procedurally fair.
AMA J Ethics. 2017;19(11):1073-1080. doi:
10.1001/journalofethics.2017.19.11.ecas1-1711.
Dr Mitesh Patel joins us on this episode of Ethics Talk to discuss nudges, how they can be used effectively in health care, and how to identify and avoid the potential ethical pitfalls of guiding behavior.
Parents’ false beliefs can be engaged respectfully to motivate deliberations about shared values and goals, but refusal of clinically indicated treatment could warrant reporting.
AMA J Ethics. 2018;20(11):E1017-1024. doi:
10.1001/amajethics.2018.1017.
Patients have a right to decline or withdraw LVADs. Informed consent and shared decision making is not easy, however, with treatments that are high risk, high reward.
AMA J Ethics. 2019;21(5):E394-400. doi:
10.1001/amajethics.2019.394.
Sara Silbert, MD, Gregory A. Yanik, MD, and Andrew G. Shuman, MD
“Living” drugs target specific B-cell malignancy tumor antigens, but cost hundreds of thousands of dollars. Value analysis can help determine whether to offer these customized drugs.
AMA J Ethics. 2019;21(10):E844-851. doi:
10.1001/amajethics.2019.844.
Decision making in health care demands that we balance multiple considerations, like quality of life, statistics, and how different options could affect others. Dr Brian Zikmund-Fisher shares his own experience as a patient and explains how decision science can help us navigate ethically complex health decisions.